Arenaria serpyllifolia as a Natural Antiviolaceum Agent: Phytochemical, Biological, and Molecular Approaches


KÜLAHCI M. B., AYDIN B., Torunoğlu E. I., Düzgün Z., Durmaz A., AYTAR E. C.

ChemistryOpen, cilt.14, sa.11, 2025 (SCI-Expanded, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 14 Sayı: 11
  • Basım Tarihi: 2025
  • Doi Numarası: 10.1002/open.202500236
  • Dergi Adı: ChemistryOpen
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, Chemical Abstracts Core, EMBASE, MEDLINE, Directory of Open Access Journals
  • Anahtar Kelimeler: antibiofilm activity, antimicrobial activity, antioxidant activity, antiquorum sensing, Arenaria serpyllifolia, molecular docking, molecular dynamics simulations
  • Uşak Üniversitesi Adresli: Evet

Özet

This study investigates the antioxidant, antimicrobial, antibiofilm, and antiquorum sensing activities of Arenaria serpyllifolia extract. A methanolic extract from the plant's above-ground parts is prepared via maceration. The extract exhibits strong antioxidant properties (DPPH IC50: 355.54 ± 20.62 μg mL−1) and iron chelating ability (IC50: 5.30 ± 4.44 mg mL−1). Total flavonoid and phenolic contents are 75.15 ± 2.73 mg quercetin equivalent g−1 and 150.83 ± 11.24 mg gallic acid equivalent g−1, respectively. Antimicrobial tests show notable activity against Chromobacterium violaceum (minimal inhibitory concentration (MIC) < 5 mg mL−1). Antibiofilm effects are significant with 82.52% and 81.32% inhibition at MIC and sub-MIC levels. The extract also inhibits violacein production in the C. violaceum CV12472 strain (90.76% at MIC). Gas chromatography-mass spectrometry analysis identifies seven major compounds, including allyl isothiocyanate and levoglucosan. Molecular docking reveals levoglucosan as the most potent CviR receptor binder (−6.8 kcal mol−1). These interactions suggest possible quorum sensing inhibition via antagonism. Molecular dynamics simulations confirm the stability of the ligand–receptor complexes, highlighting guanosine and levoglucosan as promising leads for drug development.